Le cluster efficacy - refractory

Terms

7	efficacy
4	refractory
5	immune

Associations

Freq.	Weight	Association
2	0.378	efficacy - refractory
2	0.338	efficacy - immune

Documents par ordre de pertinence

000347 (2005)	Rami Kotb [France] ; Caroline Pinganaud [France] ; Catherine Trichet [France] ; Olivier Lambotte [France] ; Marie Dreyfus [France] ; Jean-François Delfraissy [France] ; Gil Tchernia [France] ; Cécile Goujard [France]	Efficacy of mycophenolate mofetil in adult refractory auto‐immune cytopenias: a single center preliminary study
000030 (2019)	Mercedes Segovia [Uruguay] ; Sofia Russo [Uruguay] ; Mathias Jeldres [Uruguay] ; Yamil D. Mahmoud [Argentine] ; Valentina Perez [Uruguay] ; Maite Duhalde [Uruguay] ; Pierre Charnet [France] ; Matthieu Rousset [France] ; Sabina Victoria [Uruguay] ; Florencia Veigas [Argentine] ; Cédric Louvet [France] ; Bernard Vanhove [France] ; R. Andrés Floto [Royaume-Uni] ; Ignacio Anegon [France] ; Maria Cristina Cuturi [France] ; M. Romina Girotti [Argentine] ; Gabriel A. Rabinovich [Argentine] ; Marcelo Hill [Uruguay]	Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation
000300 (2008)	A. Delluc [France] ; N. Limal [France] ; X. Puéchal [France] ; C. Francès [France] ; J C Piette [France] ; P. Cacoub [France]	Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome
000089 (2018)	Cécile Rotenberg [France] ; Valérie Besnard [France] ; Pierre-Yves Brillet [France] ; Stéphane Giraudier [France] ; Hilario Nunes [France] ; Dominique Valeyre [France]	Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia.
000100 (2017-05)	Ombeline Roche ; Nathalie Aladjidi ; Josué Rakotonjanahary ; Guy Leverger ; Thierry Leblanc ; Caroline Thomas ; Marlène Pasquet ; Mary-France Courcoux ; Sophie Bayart ; Marion Gilibert-Yvert ; Bénédicte Neven ; Pierre Quartier ; Isabelle Pellier [France]	Evaluation of the efficiency of hydroxychloroquine in treating children with immune thrombocytopenia (ITP)
000119 (2016-04)	François Chasset [France] ; Laurent Arnaud [France] ; Nathalie Costedoat-Chalumeau [France] ; Noël Zahr [France] ; Didier Bessis [France] ; Camille Francès [France]	The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study
000160 (2015)	C. Saintes [France] ; M. Saint-Jean [France] ; J. J. Renaut [France] ; B. Dréno [France] ; G. Quéreux [France]	Dramatic efficacy of brentuximab vedotin in two patients with epidermotropic cutaneous T‐cell lymphomas after treatment failure despite variable CD30 expression
000204 (2013)	Mirko Paiardini [États-Unis] ; Michaela Müller-Trutwin [France]	HIV‐associated chronic immune activation
000227 (2012)	Jean-Nicolas Boursiquot [Canada] ; Laurence Gérard [France] ; Marion Malphettes [France] ; Claire Fieschi [France] ; Lionel Galicier [France] ; David Boutboul [France] ; Raphael Borie [France] ; Jean-François Viallard [France] ; Pauline Soulas-Sprauel [France] ; Alice Berezne [France] ; Arnaud Jaccard [France] ; Eric Hachulla [France] ; Julien Haroche [France] ; Nicolas Schleinitz [France] ; Laurent Têtu [France] ; Eric Oksenhendler [France]	Granulomatous Disease in CVID: Retrospective Analysis of Clinical Characteristics and Treatment Efficacy in a Cohort of 59 Patients
000253 (2010)	R. Colisson [France] ; L. Barblu [France] ; C. Gras [France] ; F. Raynaud [France] ; R. Hadj-Slimane [France] ; C. Pique [France] ; O. Hermine [France] ; Y. Lepelletier [France] ; J. P. Herbeuval [France]	Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoïd dendritic cells.
000254 (2010)	Solange Youdom Whegang ; Rachida Tahar ; Vincent Ngane Foumane ; Georges Soula ; Henri Gwét ; Jean-Christophe Thalabard [France] ; Leonardo K. Basco	Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.
000344 (2005)	J-E Gottenberg [France] ; L. Guillevin [France] ; O. Lambotte ; B. Combe [France] ; Y. Allanore [France] ; A. Cantagrel [France] ; C. Larroche [France] ; M. Soubrier [France] ; L. Bouillet [France] ; M. Dougados [France] ; O. Fain [France] ; D. Farge [France] ; X. Kyndt [France] ; O. Lortholary [France] ; C. Masson [France] ; B. Moura [France] ; P. Remy [France] ; T. Thomas [France] ; D. Wendling [France] ; J-M Anaya [Colombie] ; J. Sibilia [France] ; X. Mariette [France]	Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021